Your browser doesn't support javascript.
loading
Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis.
Kassis, Ibrahim; Ben-Zwi, Moriel; Petrou, Panayiota; Halimi, Michele; Karussis, Dimitrios.
Afiliación
  • Kassis I; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel. Electronic address: ibrahimk@hadassah.org.il.
  • Ben-Zwi M; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
  • Petrou P; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
  • Halimi M; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
  • Karussis D; Unit of Neuroimmunology and Multiple Sclerosis Center, Hadassah University Hospital, Jerusalem, Ein-Kerem, Israel.
Immunol Lett ; 233: 11-19, 2021 05.
Article en En | MEDLINE | ID: mdl-33676976

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Encefalomielitis Autoinmune Experimental / Células Madre Mesenquimatosas / Clorhidrato de Fingolimod Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunol Lett Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Encefalomielitis Autoinmune Experimental / Células Madre Mesenquimatosas / Clorhidrato de Fingolimod Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunol Lett Año: 2021 Tipo del documento: Article